Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • colinmolter
    Member
    • Jul 2011
    • 11

    #1

    cuffdiff2 fails to find diff expressed genes!!??

    Hello,

    I processed 8 breast cancer samples, 4ER+ and 4ER- using tophat2/cufflinks2/cuffmerge2/cuffdiff2/cummeRbund.

    The expression of the gene GREB1 is nearly equal to 0 for the 4 ER-
    and ~100 for ER+:

    cuff <- readCufflinks()
    expr=repFpkmMatrix(genes(cuff))
    expr[rownames(expr)=='XLOC_011466',]
    Neg_0 Neg_1 Neg_2 Neg_3 Pos_0 Pos_1 Pos_2 Pos_3
    XLOC_011466 0.182529 0.791468 0.721075 0.15861 35.9609 231.247 64.1414 39.4893

    However, the result of cuffdiff is:
    diffData(getGene(cuff, 'GREB1'))
    gene_id sample_1 sample_2 status value_1 value_2
    log2_fold_change test_stat p_value q_value significant
    1 XLOC_011466 Neg Pos OK 0.460534 92.726
    7.65352 -1.1267 0.25987 0.999954 no

    How can you explain this. It seems not consistent for me. I would have
    expected a nice q value, a significant test, etc.

    thanks for feedbacks,
    colin

    ps. data were downloaded from SRA/GEO : GSE27003 and are available at inSilico: https://insilico.ulb.ac.be/app/browse?q=GSE27003

Latest Articles

Collapse

  • SEQadmin2
    How Immunogenomics Decodes Immunity’s Genetic Blueprint
    by SEQadmin2




    The immune system’s power comes from its genetic diversity, allowing myriad threats to be neutralized through first recognizing foreign antigens. That diversity is also what makes the immune system so difficult to study. Recent advances in sequencing technology and computational biology, however, are giving researchers new tools to understand immune responses and immune-related diseases in greater detail.

    This convergence of genetics, immunology, and computation...
    Today, 05:41 AM
  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 08-24-2026, 10:32 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-20-2026, 11:17 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-18-2026, 10:05 AM
0 responses
53 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-13-2026, 12:22 PM
0 responses
50 views
0 reactions
Last Post SEQadmin2  
Working...